Research Summary
NK Cell Therapy, or Natural Killer Cell Therapy, is an innovative immunotherapy that utilizes natural killer (NK) cells to fight cancer. NK cells are a type of white blood cell that play a crucial role in the body’s innate immune response by identifying and destroying infected or cancerous cells without the need for prior sensitization. In NK cell therapy, NK cells are either extracted from the patient (autologous) or from a donor (allogeneic), expanded and activated in the laboratory, and then infused back into the patient to target and kill cancer cells. This therapy harnesses the natural cancer-fighting properties of NK cells to selectively attack tumors while minimizing damage to healthy tissues. NK cell therapy has shown promise in treating various cancers, including leukemia, lymphoma, and solid tumors, and it is being explored as an adjunct or alternative to more traditional cancer treatments like chemotherapy and radiation. One of the key advantages of NK cell therapy is its relatively low risk of graft-versus-host disease (GVHD), especially when using autologous NK cells, compared to other forms of immune cell therapies like T cell therapies. However, challenges such as the difficulty of expanding NK cells at large scales and ensuring their persistence and activity in the body remain. Ongoing research continues to optimize NK cell therapy for wider clinical use.
According to WENKH research statistics, the global NK Cell Therapy market size will reach 670.12 Million USD in 2026 and is projected to reach 2,156.27 Million USD by 2033, with a CAGR of 18.17% (2026-2033). Among them, the Asia-Pacific NK Cell Therapy market is undergoing rapid changes, reaching Million USD in 2026, accounting for approximately % of the global market share. It is projected to reach Million USD by 2033.
The global NK Cell Therapy market is highly competitive, with key market players including Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech, etc. This report categorizes the competitive landscape of the global NK Cell Therapy market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global NK Cell Therapy market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global NK Cell Therapy industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of NK Cell Therapy and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2021 to 2025, providing a solid foundation for analyzing past market trends. The year 2026 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2027 to 2033, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of NK Cell Therapy in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the NK Cell Therapy market. By considering local policies, this report evaluates the market prospects of NK Cell Therapy in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Nektar Therapeutics
Innate Pharma
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Product Segment
NK Cell Therapies
NK Cell Directed Antibodies
Product Application
Cancer
Gastrointestinal Diseases
Others
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global NK Cell Therapy Industry Chain Analysis
Chapter 3: Global NK Cell Therapy Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global NK Cell Therapy Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)
Chapter 6: Global NK Cell Therapy Market Analysis by Countries, Product Segment and Downstream Application
Chapter 7: United States NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 8: China NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 9: Germany NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 10: Japan NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 11: France NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 12: South Korea NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 13: United Kingdom NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 14: India NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 15: Italy NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 16: Brazil NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 17: Mexico NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 18: Indonesia NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 19: Vietnam NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 20: South Africa NK Cell Therapy Market Size, Product Segment, Downstream Application Analysis
Chapter 21: Research Conclusion
Chapter 22: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Content
1 NK Cell Therapy Market Overview
1.1 Product Definition Introduction
1.2 Global NK Cell Therapy Market Size and Growth Forecast Analysis (2021-2033)
1.3 NK Cell Therapy Market Status and Development Prospects
1.3.1 NK Cell Therapy Market Status
1.3.2 NK Cell Therapy Industry Development Prospects
1.4 NK Cell Therapy Market Overview by Product Segment
1.4.1 Global NK Cell Therapy Market Size and Growth Forecast Analysis by Product Segment: 2021 VS 2026 VS 2033
1.4.2 NK Cell Therapies
1.4.3 NK Cell Directed Antibodies
1.5 NK Cell Therapy Market Overview by Product Application
1.5.1 Global NK Cell Therapy Market Size and Growth Forecast Analysis by Product Application: 2021 VS 2026 VS 2033
1.5.2 Cancer
1.5.3 Gastrointestinal Diseases
1.5.4 Others
2 NK Cell Therapy Industry Supply Chain Analysis
2.1 NK Cell Therapy Supply Chain
2.2 NK Cell Therapy Midstream Suppliers
2.3 NK Cell Therapy Downstream Customers
2.4 NK Cell Therapy Sales Channel Analysis
3 NK Cell Therapy Market Environment Analysis
3.1 NK Cell Therapy Industry Policy Analysis
3.2 NK Cell Therapy Emerging Technology Trends in the Industry
3.3 NK Cell Therapy Restraining Factors Analysis
3.4 NK Cell Therapy Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global NK Cell Therapy Market Players Competition Landscape
4.1 Global NK Cell Therapy Market Revenue by Key Players (2021-2026)
4.2 Global NK Cell Therapy Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global NK Cell Therapy Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Nektar Therapeutics
5.1.1 Nektar Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Nektar Therapeutics NK Cell Therapy Product Features
5.1.3 Nektar Therapeutics NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.2 Innate Pharma
5.2.1 Innate Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 Innate Pharma NK Cell Therapy Product Features
5.2.3 Innate Pharma NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.3 Affimed
5.3.1 Affimed Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Affimed NK Cell Therapy Product Features
5.3.3 Affimed NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.4 Chipscreen Biosciences
5.4.1 Chipscreen Biosciences Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Chipscreen Biosciences NK Cell Therapy Product Features
5.4.3 Chipscreen Biosciences NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.5 Fate Therapeutics
5.5.1 Fate Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 Fate Therapeutics NK Cell Therapy Product Features
5.5.3 Fate Therapeutics NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.6 Glycostem Therapeutics
5.6.1 Glycostem Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Glycostem Therapeutics NK Cell Therapy Product Features
5.6.3 Glycostem Therapeutics NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.7 Dragonfly Therapeutics
5.7.1 Dragonfly Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Dragonfly Therapeutics NK Cell Therapy Product Features
5.7.3 Dragonfly Therapeutics NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.8 Kiadis Pharma
5.8.1 Kiadis Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Kiadis Pharma NK Cell Therapy Product Features
5.8.3 Kiadis Pharma NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.9 NantWorks
5.9.1 NantWorks Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 NantWorks NK Cell Therapy Product Features
5.9.3 NantWorks NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.10 Nkarta Therapeutics
5.10.1 Nkarta Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Nkarta Therapeutics NK Cell Therapy Product Features
5.10.3 Nkarta Therapeutics NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
5.11 Fortress Biotech
5.11.1 Fortress Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 Fortress Biotech NK Cell Therapy Product Features
5.11.3 Fortress Biotech NK Cell Therapy Product Revenue and Gross Margin Analysis (2021-2026)
6 Global NK Cell Therapy Market Analysis by Countries, by Product Segment and Application
6.1 Global NK Cell Therapy Market Size and Growth Forecast by Countries: 2021 VS 2026 VS 2033
6.1.1 Global NK Cell Therapy Market Revenue by Countries (2021-2026)
6.1.2 Global NK Cell Therapy Market Revenue Forecast by Countries (2027-2033)
6.2 Global NK Cell Therapy Market Size by Product Segment (2021-2033)
6.3 Global NK Cell Therapy Market Size by Product Application (2021-2033)
7 United States NK Cell Therapy Market Analysis
7.1 United States NK Cell Therapy Market Prospects
7.2 United States NK Cell Therapy Market Size by Product Segment (2021-2033)
7.3 United States NK Cell Therapy Market Size by Product Application (2021-2033)
8 China NK Cell Therapy Market Analysis
8.1 China NK Cell Therapy Market Prospects
8.2 China NK Cell Therapy Market Size by Product Segment (2021-2033)
8.3 China NK Cell Therapy Market Size by Product Application (2021-2033)
9 Germany NK Cell Therapy Market Analysis
9.1 Germany NK Cell Therapy Market Prospects
9.2 Germany NK Cell Therapy Market Size by Product Segment (2021-2033)
9.3 Germany NK Cell Therapy Market Size by Product Application (2021-2033)
10 Japan NK Cell Therapy Market Analysis
10.1 Japan NK Cell Therapy Market Prospects
10.2 Japan NK Cell Therapy Market Size by Product Segment (2021-2033)
10.3 Japan NK Cell Therapy Market Size by Product Application (2021-2033)
11 France NK Cell Therapy Market Analysis
11.1 France NK Cell Therapy Market Prospects
11.2 France NK Cell Therapy Market Size by Product Segment (2021-2033)
11.3 France NK Cell Therapy Market Size by Product Application (2021-2033)
12 South Korea NK Cell Therapy Market Analysis
12.1 South Korea NK Cell Therapy Market Prospects
12.2 South Korea NK Cell Therapy Market Size by Product Segment (2021-2033)
12.3 South Korea NK Cell Therapy Market Size by Product Application (2021-2033)
13 United Kingdom NK Cell Therapy Market Analysis
13.1 United Kingdom NK Cell Therapy Market Prospects
13.2 United Kingdom NK Cell Therapy Market Size by Product Segment (2021-2033)
13.3 United Kingdom NK Cell Therapy Market Size by Product Application (2021-2033)
14 India NK Cell Therapy Market Analysis
14.1 India NK Cell Therapy Market Prospects
14.2 India NK Cell Therapy Market Size by Product Segment (2021-2033)
14.3 India NK Cell Therapy Market Size by Product Application (2021-2033)
15 Italy NK Cell Therapy Market Analysis
15.1 Italy NK Cell Therapy Market Prospects
15.2 Italy NK Cell Therapy Market Size by Product Segment (2021-2033)
15.3 Italy NK Cell Therapy Market Size by Product Application (2021-2033)
16 Brazil NK Cell Therapy Market Analysis
16.1 Brazil NK Cell Therapy Market Prospects
16.2 Brazil NK Cell Therapy Market Size by Product Segment (2021-2033)
16.3 Brazil NK Cell Therapy Market Size by Product Application (2021-2033)
17 Mexico NK Cell Therapy Market Analysis
17.1 Mexico NK Cell Therapy Market Prospects
17.2 Mexico NK Cell Therapy Market Size by Product Segment (2021-2033)
17.3 Mexico NK Cell Therapy Market Size by Product Application (2021-2033)
18 Indonesia NK Cell Therapy Market Analysis
18.1 Indonesia NK Cell Therapy Market Prospects
18.2 Indonesia NK Cell Therapy Market Size by Product Segment (2021-2033)
18.3 Indonesia NK Cell Therapy Market Size by Product Application (2021-2033)
19 Vietnam NK Cell Therapy Market Analysis
19.1 Vietnam NK Cell Therapy Market Prospects
19.2 Vietnam NK Cell Therapy Market Size by Product Segment (2021-2033)
19.3 Vietnam NK Cell Therapy Market Size by Product Application (2021-2033)
20 South Africa NK Cell Therapy Market Analysis
20.1 South Africa NK Cell Therapy Market Prospects
20.2 South Africa NK Cell Therapy Market Size by Product Segment (2021-2033)
20.3 South Africa NK Cell Therapy Market Size by Product Application (2021-2033)
21 Research Conclusion
22 Appendix
22.1 Methodology/Research Approach
22.2 Research Landscape
22.3 Research Benchmark and Hypothesis
22.4 Data Source
22.4.1 Primary Sources
22.4.2 Secondary Sources
22.5 Data Cross Validation
22.6 Disclaimer
Table 1：Global NK Cell Therapy Market Size and Growth Forecast Analysis by Product Segment (2021 VS 2026 VS 2033) & (Million USD)
Table 2：Global NK Cell Therapy Market Size and Growth Forecast Analysis by Product Application (2021 VS 2026 VS 2033) & (Million USD)
Table 3：NK Cell Therapy Downstream Customers List
Table 4：NK Cell Therapy Distributors/Dealers List
Table 5：Global NK Cell Therapy Market Revenue by Key Players (2021-2026) & (Million USD)
Table 6：Global NK Cell Therapy Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global NK Cell Therapy Market Expansion and M&A Dynamic
Table 9：Nektar Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Nektar Therapeutics NK Cell Therapy Product Features
Table 11：Nektar Therapeutics NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 12：Innate Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 13：Innate Pharma NK Cell Therapy Product Features
Table 14：Innate Pharma NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 15：Affimed Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 16：Affimed NK Cell Therapy Product Features
Table 17：Affimed NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 18：Chipscreen Biosciences Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 19：Chipscreen Biosciences NK Cell Therapy Product Features
Table 20：Chipscreen Biosciences NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 21：Fate Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 22：Fate Therapeutics NK Cell Therapy Product Features
Table 23：Fate Therapeutics NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 24：Glycostem Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Glycostem Therapeutics NK Cell Therapy Product Features
Table 26：Glycostem Therapeutics NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 27：Dragonfly Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 28：Dragonfly Therapeutics NK Cell Therapy Product Features
Table 29：Dragonfly Therapeutics NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 30：Kiadis Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 31：Kiadis Pharma NK Cell Therapy Product Features
Table 32：Kiadis Pharma NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 33：NantWorks Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 34：NantWorks NK Cell Therapy Product Features
Table 35：NantWorks NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 36：Nkarta Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 37：Nkarta Therapeutics NK Cell Therapy Product Features
Table 38：Nkarta Therapeutics NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 39：Fortress Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：Fortress Biotech NK Cell Therapy Product Features
Table 41：Fortress Biotech NK Cell Therapy Revenue (Million USD) and Gross Margin (2021-2026)
Table 42：Global NK Cell Therapy Market Size and Growth Forecast by Countries (2021 VS 2026 VS 2033) & (Million USD)
Table 43：Global NK Cell Therapy Market Revenue by Countries (2021-2026) & (Million USD)
Table 44：Global NK Cell Therapy Market Share by Countries (2021-2026)
Table 45：Global NK Cell Therapy Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 46：Global NK Cell Therapy Market Share Forecast by Countries (2027-2033)
Table 47：Global NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 48：Global NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 49：Global NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 50：Global NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 51：United States NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 52：United States NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 53：United States NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 54：United States NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 55：China NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 56：China NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 57：China NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 58：China NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 59：Germany NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 60：Germany NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 61：Germany NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 62：Germany NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 63：Japan NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 64：Japan NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 65：Japan NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 66：Japan NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 67：France NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 68：France NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 69：France NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 70：France NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 71：South Korea NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 72：South Korea NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 73：South Korea NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 74：South Korea NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 75：United Kingdom NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 76：United Kingdom NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 77：United Kingdom NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 78：United Kingdom NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 79：India NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 80：India NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 81：India NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 82：India NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 83：Italy NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 84：Italy NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 85：Italy NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 86：Italy NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 87：Brazil NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 88：Brazil NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 89：Brazil NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 90：Brazil NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 91：Mexico NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 92：Mexico NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 93：Mexico NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 94：Mexico NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 95：Indonesia NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 96：Indonesia NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 97：Indonesia NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 98：Indonesia NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 99：Vietnam NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 100：Vietnam NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 101：Vietnam NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 102：Vietnam NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 103：South Africa NK Cell Therapy Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 104：South Africa NK Cell Therapy Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 105：South Africa NK Cell Therapy Market Revenue by Product Application (2021-2026) & (Million USD)
Table 106：South Africa NK Cell Therapy Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 107：Secondary Sources
Figure 1：NK Cell Therapy Product Scope
Figure 2：Global NK Cell Therapy Market Size and Growth Forecast Analysis (2021-2033) & (Million USD)
Figure 3：Global NK Cell Therapy Product Segment Market Share (2026 & 2033)
Figure 4：Global NK Cell Therapy Product Application Market Share (2026 & 2033)
Figure 5：NK Cell Therapies Product Scope
Figure 6：NK Cell Directed Antibodies Product Scope
Figure 7：Cancer Product Scope
Figure 8：Gastrointestinal Diseases Product Scope
Figure 9：Others Product Scope
Figure 10：NK Cell Therapy Industrial Chain Framework
Figure 11：Global NK Cell Therapy Market by Geographic Segmentation in 2026
Figure 12：Global NK Cell Therapy Market Share by Countries (2021 VS 2026)
Figure 13：United States NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 14：China NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 15：Germany NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 16：Japan NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 17：France NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 18：South Korea NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 19：United Kingdom NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 20：India NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 21：Italy NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 22：Brazil NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 23：Mexico NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 24：Indonesia NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 25：Vietnam NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 26：South Africa NK Cell Therapy Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 27：Research Methodology
Figure 28：Primary Sources
Figure 29：Data Cross Validation
Global NK Cell Therapy Revenue and Market Share by Key Players
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Nektar Therapeutics | XX | XX | XX | XX | XX |
| Innate Pharma | XX | XX | XX | XX | XX |
| Affimed | XX | XX | XX | XX | XX |
| Chipscreen Biosciences | XX | XX | XX | XX | XX |
| Fate Therapeutics | XX | XX | XX | XX | XX |
| Glycostem Therapeutics | XX | XX | XX | XX | XX |
| Dragonfly Therapeutics | XX | XX | XX | XX | XX |
| Kiadis Pharma | XX | XX | XX | XX | XX |
| NantWorks | XX | XX | XX | XX | XX |
| Nkarta Therapeutics | XX | XX | XX | XX | XX |
| Fortress Biotech | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
English
Related Reports 
